Pfizer Inc.s top viral vaccine-science executive is leaving the pharmaceutical giant for rival GlaxoSmithKline PLC, a high-profile industry move that comes as Pfizer and other vaccine makers scramble...
Airlines are warning of lower bookings, executives in Europe are tweaking business travel plans and a handful of organizations have canceled or downscaled events across the continent amid new governm...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/N4L3J25AGNJYTPAHTT3CUY5VAQ.jpg)
FRANKFURT, Nov 30 (Reuters) - BioNTech and Pfizer's (PFE.N) COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Execut...
A Social Security Administration office in San Francisco. One of the most immediate effects at the onset of the Covid-19 outbreak early last year was an upheaval in the workforce. Now, almost two y...
The volatile but never boring market for Bitcoin (BTC) has been whipsawed in recent days, as investors ponder whether there are better returns to be had in other cryptocurrencies, even as a new COVID...
GlaxoSmithKline is poaching Pfizer's vaccine guru after failing to produce its own Covid jab following a series of setbacks earlier in the pandemic. GSK said Phil Dormitzer will join as its global h...